Evogene Reports First Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Evogene (EVGN) Misses Q4 EPS by 3c
May 26, 2022 7:04 AM EDTEvogene (NASDAQ: EVGN) reported Q4 EPS of ($0.20), $0.03 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $237 thousand versus the consensus estimate of $270 thousand.
For earnings history and earnings-related data on Evogene (EVGN) click here.
... More


